Value for money of medicine sampling and quality testing: evidence from Indonesia.

ABSTRACT:

Background

Substandard and falsified medicines (SFMs) are a public health concern of global importance. Postmarket surveillance in the form of medicine sampling and quality testing can prevent and detect SFM, however, there is remarkably scarce evidence about the cost and value for money of these activities: how much do they cost and how effective are they in detecting SFM?

Methods

Between February and October 2022, Systematic Tracking of At Risk Medicines (STARmeds) collected and analysed for quality 1274 samples of 5 medicines from physical and online retail outlets in 7 Indonesian districts. We collated data on the resources consumed by STARmeds, related to all stages of medicines sampling and quality testing including design, fieldwork and laboratory analysis. We used ac

SUBMITTER: Valente de Almeida S 

PROVIDER: S-EPMC11429347 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature